3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Hemangiosarcoma
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Disease Progression
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pertuzumab
5
Trastuzumab
5
Docetaxel
3
tucatinib
2
pyrotinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Injections
1
Genetic Testing
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
neratinib
×
90 days
×
Clear all
No trials found.